NO308196B1 - Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen - Google Patents

Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen

Info

Publication number
NO308196B1
NO308196B1 NO951718A NO951718A NO308196B1 NO 308196 B1 NO308196 B1 NO 308196B1 NO 951718 A NO951718 A NO 951718A NO 951718 A NO951718 A NO 951718A NO 308196 B1 NO308196 B1 NO 308196B1
Authority
NO
Norway
Prior art keywords
doxazosin
drug
manufacture
treatment
benign prostatic
Prior art date
Application number
NO951718A
Other languages
English (en)
Norwegian (no)
Other versions
NO951718D0 (no
NO951718L (no
Inventor
Nancy M Gray
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO951718D0 publication Critical patent/NO951718D0/no
Publication of NO951718L publication Critical patent/NO951718L/no
Publication of NO308196B1 publication Critical patent/NO308196B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
NO951718A 1992-11-04 1995-05-03 Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen NO308196B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97068592A 1992-11-04 1992-11-04
PCT/US1993/010503 WO1994009785A2 (en) 1992-11-04 1993-11-02 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis

Publications (3)

Publication Number Publication Date
NO951718D0 NO951718D0 (no) 1995-05-03
NO951718L NO951718L (no) 1995-05-03
NO308196B1 true NO308196B1 (no) 2000-08-14

Family

ID=25517324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951718A NO308196B1 (no) 1992-11-04 1995-05-03 Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen

Country Status (11)

Country Link
US (1) US5508279A (ko)
EP (1) EP0667775A1 (ko)
JP (1) JPH08502977A (ko)
KR (1) KR950703961A (ko)
AU (1) AU5546194A (ko)
CA (1) CA2147866A1 (ko)
HU (1) HU219482B (ko)
NO (1) NO308196B1 (ko)
NZ (1) NZ257993A (ko)
RU (1) RU2139053C1 (ko)
WO (1) WO1994009785A2 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120302A0 (en) * 1996-03-27 1997-06-10 Pfizer Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6177430B1 (en) 1997-03-27 2001-01-23 Pfizer Inc Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
IL141235A (en) * 2000-02-09 2012-04-30 Novartis Int Pharm Ltd Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the preparation of a drug for the treatment of non-malignant prostatic hyperplasia
US6596686B2 (en) 2001-03-12 2003-07-22 International Flavors & Fragrances Inc. Use of dihydropyrans as fragrance Material
DK1443917T3 (da) * 2001-11-07 2006-07-17 Synthon Bv Tamsulosintabletter
US7175127B2 (en) * 2002-09-27 2007-02-13 C.G. Bretting Manufacturing Company, Inc. Rewinder apparatus and method
KR20050092519A (ko) * 2004-03-16 2005-09-22 화이자 인코포레이티드 아토르바스타틴 및 α1-아드레날린성 수용체 길항제의 조합
WO2006031024A1 (en) * 2004-09-15 2006-03-23 Gl Pharmtech Corp. A sustained-release tablet containing doxazosin mesylate
CN1769285B (zh) * 2004-11-05 2010-05-05 华北制药集团新药研究开发有限责任公司 光学活性的多沙唑嗪盐
CN102260249B (zh) * 2005-11-11 2013-11-13 华北制药集团新药研究开发有限责任公司 (-)多沙唑嗪甲磺酸盐ⅱ型结晶、其制备方法及用途
CN107951852A (zh) * 2017-12-31 2018-04-24 威海贯标信息科技有限公司 一种多沙唑嗪片组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
IL101243A (en) * 1991-03-20 1999-12-22 Merck & Co Inc Pharmaceutical preparations for the treatment of benign prostatic hyperplasia containing steroid history

Also Published As

Publication number Publication date
WO1994009785A2 (en) 1994-05-11
RU2139053C1 (ru) 1999-10-10
JPH08502977A (ja) 1996-04-02
NO951718D0 (no) 1995-05-03
NO951718L (no) 1995-05-03
HUT73678A (en) 1996-09-30
KR950703961A (ko) 1995-11-17
WO1994009785A3 (en) 1994-08-04
EP0667775A1 (en) 1995-08-23
US5508279A (en) 1996-04-16
HU219482B (hu) 2001-04-28
HU9501286D0 (en) 1995-06-28
NZ257993A (en) 1997-05-26
AU5546194A (en) 1994-05-24
CA2147866A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
EP0667769A4 (en) USE OF SPECIFIC ALPHA-1C COMPOUNDS IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA.
DK288590D0 (da) Blandings/oploesnings-sproejte til cytostatika for medicinsk behandling af cancer patienter
NO308196B1 (no) Anvendelse av (+)doksazosin for fremstilling av et medikament for behandling av godartet prostatisk hyperplasi for Õ øke urinstrømmen
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
DE69320034T2 (de) Autoperfusions-dilationskatheter
FR2698780B1 (fr) Catheter pour le traitement d'un tissu pathologique.
DK1206261T3 (da) Farmaceutiske præparater, der omfatter clavuansyre eller derivater deraf, til behandlingen af adfærdsmæssige sygdomme
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
HUP0000558A2 (hu) Aktív D-vitamin analógok alkalmazása prosztatabetegségek kezelésére szolgáló gyógyszerkészítmények előállítására
KR950700749A (ko) 2'-할로메틸리덴 유도체와 S-기 또는 M-기 특이성 항종양제를 사용하는 결합치료에 의한 암치료 방법(Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
DK0811376T3 (da) Anvendelse af alkanoyl-L-carnitiner til fremstilling af et lægemiddel til behandling af inflammatoriske tarmsygdomme
ITMI910219A1 (it) Procedimento per il trattamento di terra da fonderia e/o per anime
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
NO942756D0 (no) Behandling av glaucoma
NO992985D0 (no) Anvendelse av COMT inhibitorer for fremstilling av et legemiddel til Õ forhindre diabetisk vaskulµr dysfunksjon
EP0733365A3 (en) Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer
AU5457694A (en) Methods and compositions of (-) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
NO975838D0 (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
ITMI920873A0 (it) Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
DE69133542D1 (de) Katheter zur Behandlung von Prostaterkrankungen
RU92007680A (ru) Средство, обладающее тонизирующим действием на гладкую мускулатуру вен, мочевого пузыря и предстательной железы
KR940021644U (ko) 수용성 약재 연무기의 분사관
FI961492A0 (fi) Terapeutiskt och profylaktiskt foerfarande foer bekaempande av skadliga mikrober och aemnen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003